XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
Common Stock [Member]
At The Market Offering Agreement [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Related Party Convertible Debt Price Reset [Member]
Additional Paid-in Capital [Member]
At The Market Offering Agreement [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Related Party Convertible Debt Price Reset [Member]
At The Market Offering Agreement [Member]
Total
Balance (in shares) at Dec. 31, 2021   279,629                        
Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021     $ (10,681,000)       $ 9,739,000       $ (942,000)      
Balance at Dec. 31, 2021           $ 268,459,000   $ (264,662,000) $ 31,000 [1] $ (431,000)       $ 3,397,000
Stock-based compensation expense           42,000               42,000
Related party convertible note price reset       $ 213,000               $ 213,000    
Sale of common stock and warrants, net (in shares) 20,407                          
Sale of common stock and warrants, net         $ 594,000               $ 594,000  
Foreign currency translation gain                 14,000 [1]         14,000
Net loss               (1,910,000)   (126,000)       (2,036,000)
Balance (in shares) at Mar. 31, 2022   300,036                        
Balance at Mar. 31, 2022           258,627,000   (256,833,000) 45,000 [1] (557,000)       1,282,000
Balance (in shares) at Dec. 31, 2021   279,629                        
Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021     $ (10,681,000)       $ 9,739,000       $ (942,000)      
Balance at Dec. 31, 2021           268,459,000   (264,662,000) 31,000 [1] (431,000)       3,397,000
Foreign currency translation gain                           67,000
Balance (in shares) at Sep. 30, 2022   710,967                        
Balance at Sep. 30, 2022   $ 1,000       267,761,000   (262,761,000) 98,000 [1] (833,000)       4,266,000
Balance (in shares) at Mar. 31, 2022   300,036                        
Balance at Mar. 31, 2022           258,627,000   (256,833,000) 45,000 [1] (557,000)       1,282,000
Stock-based compensation expense           72,000               72,000
Related party convertible note price reset       2,475,000               2,475,000    
Conversion of note payable to common stock (in shares)   234,495                        
Conversion of note payable to common stock   $ 1,000       2,999,000               3,000,000
Sale of common stock and warrants, net (in shares) 97,726                          
Sale of common stock and warrants, net         1,450,000               1,450,000  
Foreign currency translation gain                 31,000 [1]         31,000
Net loss               (2,688,000)   (113,000)       (2,801,000)
Conversion of related party note payable to common stock (in shares)   234,495                        
Conversion of related party note payable to common stock   $ 1,000       2,999,000               3,000,000
Balance (in shares) at Jun. 30, 2022   632,257                        
Balance at Jun. 30, 2022   $ 1,000       265,623,000   (259,521,000) 76,000 [1] (670,000)       5,509,000
Stock-based compensation expense           70,000               70,000
Related party convertible note price reset       1,075,000               1,075,000    
Sale of common stock and warrants, net (in shares) 78,710                          
Sale of common stock and warrants, net         $ 993,000               $ 993,000  
Foreign currency translation gain                 22,000 [1]         22,000
Net loss               (3,240,000)   (163,000)       (3,403,000)
Balance (in shares) at Sep. 30, 2022   710,967                        
Balance at Sep. 30, 2022   $ 1,000       267,761,000   (262,761,000) 98,000 [1] (833,000)       4,266,000
Balance (in shares) at Dec. 31, 2022   1,037,138                        
Balance at Dec. 31, 2022   $ 1,000       270,377,000   (266,193,000) 111,000 (973,000)       3,323,000
Stock-based compensation expense           10,000               10,000
Related party convertible note price reset       3,160,000   43,000           3,160,000   43,000
Conversion of note payable to common stock (in shares)   215,000                        
Conversion of note payable to common stock   $ 1,000       602,000               603,000
Sale of common stock and warrants, net (in shares)   125,000                        
Sale of common stock and warrants, net           2,640,000               2,640,000
Exercise of warrants (in shares)   158,731                        
Exercise of warrants           421,000               421,000
Foreign currency translation gain                 (6,000)         (6,000)
Net loss               (5,086,000)   (96,000)       (5,182,000)
Conversion of related party note payable to common stock (in shares)   215,000                        
Conversion of related party note payable to common stock   $ 1,000       602,000               603,000
Balance (in shares) at Mar. 31, 2023   1,535,869                        
Balance at Mar. 31, 2023   $ 2,000       277,253,000   (271,279,000) 105,000 (1,069,000)       5,012,000
Balance (in shares) at Dec. 31, 2022   1,037,138                        
Balance at Dec. 31, 2022   $ 1,000       270,377,000   (266,193,000) 111,000 (973,000)       3,323,000
Related party convertible note price reset                       6,820,000    
Sale of common stock and warrants, net (in shares)                         196,843  
Foreign currency translation gain                           3,000
Balance (in shares) at Sep. 30, 2023   3,136,504                        
Balance at Sep. 30, 2023   $ 3,000       281,632,000   (277,154,000) 114,000 (1,332,000)       3,263,000
Balance (in shares) at Mar. 31, 2023   1,535,869                        
Balance at Mar. 31, 2023   $ 2,000       277,253,000   (271,279,000) 105,000 (1,069,000)       5,012,000
Stock-based compensation expense           13,000               13,000
Exercise of warrants (in shares)   946,429                        
Net loss               (2,260,000)   (138,000)       (2,398,000)
Balance (in shares) at Jun. 30, 2023   2,482,298                        
Balance at Jun. 30, 2023   $ 2,000       277,266,000   (273,539,000) 105,000 (1,207,000)       2,627,000
Stock-based compensation expense           7,000               7,000
Related party convertible note price reset       $ 3,660,000               $ 3,660,000    
Conversion of note payable to common stock (in shares)   654,206                        
Conversion of note payable to common stock   $ 1,000       699,000               700,000
Foreign currency translation gain                 9,000         9,000
Net loss               (3,615,000)   (125,000)       (3,740,000)
Conversion of related party note payable to common stock (in shares)   654,206                        
Conversion of related party note payable to common stock   $ 1,000       699,000               700,000
Balance (in shares) at Sep. 30, 2023   3,136,504                        
Balance at Sep. 30, 2023   $ 3,000       $ 281,632,000   $ (277,154,000) $ 114,000 $ (1,332,000)       $ 3,263,000
[1] Accumulated other comprehensive loss.